CJEU rejects inventive advance test in latest SPC ruling

In today’s Royalty Pharma decision, the EU’s highest court affirmed the two-step test from Teva v Gilead and dismissed another test created by Judge Arnold
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: